Skip to main content
. 2017 Feb 14;37(4):1989–1997. doi: 10.3892/or.2017.5443

Figure 1.

Figure 1.

Cisplatin IC50 of ERCC1 silencing XWLC05 cell line decreased significantly. (A and B) Efficiently ERCC1 silencing XWLC05 cell line and its control were verified by immunoblotting and real-time PCR. (C) Cisplatin IC50 of XWLC05 was 4.73 µM. (D) Cisplatin IC50 of XWLC05 ERCC1-shRNA cell line and its control were 4.54 and 1.34 µM, respectively.